Please login to the form below
Healthcare terms - F
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - F
- Fair balance
- Fast Moving Consumer Goods (FMCG)
- Fax Preference Service (FPS)
- Feature article
- Fees
- Field experiments
- Field marketing
- Focus group moderator
- Focus groups
- Focused Advertising Sampling Technique (FAST) Marketing
- Font
- Food And Drug Administration (FDA)
- Forecasting
- Formulary
- Foundation Trust (FT)
- Four Ms
- Four Ps
- Franchising
- Free market economy
- Freelancer
- Frequency
- Full-service agency
Featured jobs
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
-
Senior Copywriter
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer opens AI-enabled drug discovery center in UK
- Roche reports continued growth in Q3, despite biosimilar competition
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- The best in the UK healthcare system celebrated at QiC Diabetes awards 2019
- Merck wins CHMP recommendation for Ebola vaccine
- Roche scores another FDA approval for Xofluza
- CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal
- AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs
- A snapshot of Crescendo Biologics
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Quick links
Infographics
